Title : Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer.

Pub. Date : 2021 Jul 15

PMID : 33602685






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer. Paclitaxel erb-b2 receptor tyrosine kinase 2 Homo sapiens